Enlivex Ltd.

Contributing Author

Recent Articles by Enlivex Ltd.

Jul-20	Enlivex Treasury Portfolio Update: NAV Per Ordinary Share $66.16; Total Treasury Holdings Valued at Approximately $1.1 Billion ENLV GlobeNewswire
Jul-13	Enlivex Receives FDA Regenerative Medicine Advanced Therapy (RMAT) Designation for Allocetra in Age-Related Knee Osteoarthritis ENLV GlobeNewswire
Jul-07	Enlivex Announces 1-for-15 Reverse Stock Split Effective July 9, 2026 ENLV GlobeNewswire
Jun-24	Enlivex Treasury Portfolio Update: Listing of the RAIN Token on Gate, One of the World's Largest Cryptocurrency Exchanges by Spot Trading Volume ENLV GlobeNewswire
Jun-22	Enlivex Treasury Portfolio Update: RAIN Holdings Valued at Approximately $1.14 Billion ENLV GlobeNewswire
Jun-15	Enlivex Announces Issuance of Australian Patent Covering the Use of Allocetra in Patients with Osteoarthritis ENLV GlobeNewswire
Jun-02	ENLIVEX TO PRESENT QUALITY LONGEVITY MODEL POWERED BY PREDICTION MARKETS TREASURY AT PROOF OF TALK 2026 ENLV GlobeNewswire
Jun-01	Allocetra Shows Durable 6-Month Efficacy in Knee Osteoarthritis Phase IIa Trial; Oral Presentation at EULAR 2026 ENLV +6.55% GlobeNewswire
May-28	Enlivex Treasury Portfolio Update: RAIN Holdings Valued at Approximately $1.16 Billion; Rain Foundation Appoints Industry Leaders to Advisory Board ENLV GlobeNewswire
May-27	Enlivex Treasury Portfolio Update: Rain Protocol Jumps Into Top Three Global Prediction Markets In League Table Following $100M In Additional Liquidity ENLV +14.33% GlobeNewswire
May-18	Enlivex Announces Dosing Of First Patient In The United States As Part Of Its Phase 2b Trial of Allocetra in Age-Related Primary Moderate-to-Severe Knee Osteoarthritis ENLV GlobeNewswire
May-15	Enlivex Announces Receipt of Nasdaq Minimum Bid Price Notification ENLV GlobeNewswire
Apr-30	Enlivex Treasury Portfolio Update: Listing of the RAIN Token on HTX, a Leading Cryptocurrency Exchange ENLV GlobeNewswire
Apr-28	Enlivex Treasury Update: Total RAIN Holdings Rise to 78,819,756,062 Tokens as of April 27, 2026, Representing an Aggregated Value of $567 Million ENLV -6.38% GlobeNewswire
Apr-23	Enlivex to Present Phase IIa 3-month and 6-month Data of Allocetra at OARSI 2026 World Congress ENLV GlobeNewswire
Apr-21	Enlivex Announces Second Regulatory Approval for Phase 2b Trial of Allocetra in Age-Related Primary Moderate-to-Severe Knee Osteoarthritis ENLV GlobeNewswire
Apr-08	Ondo Global Markets Tokenizes Enlivex's Ordinary Shares ENLV +11.96% GlobeNewswire
Mar-26	Enlivex Rain Update: Rain Launches an OpenClaw and AI Agent Interface Allowing Anyone To Create A Prediction Market Via A Single Prompt ENLV -9.17% GlobeNewswire
Mar-25	Enlivex Reports Full-Year 2025 Results: Profit (Net Income) of $1.23 Billion and Diluted Earnings Per Share (EPS) of $25.48 ENLV +9.09% GlobeNewswire
Mar-24	Enlivex Announces $21 Million Debt Financing, Decentralized Prediction Markets RAIN Token-Related Updates and $20 Million Share Repurchase Program ENLV GlobeNewswire

Enlivex Ltd.

Recent Articles by Enlivex Ltd.

Upgrade your Finviz experience